Wuhan, China · Founded 2022 · Privately Held (backing)
Developer of biopharmaceutical development and production systems designed for gene therapy and vaccine research purposes. Genevoyager is based in Wuhan, China and was founded in 2022. It has raised $27.9 million.
Last price · $/share
—
Implied valuation
—
Total raised
$27.9M
Last round
—
Cap table — not yet on record
Genevoyager's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genevoyager with a free account
·Watch Genevoyager: the Monday email on marks, rounds and moves
